U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130604) titled 'Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis' on Aug. 12.
Brief Summary: This study is a randomized, double-blind, placebo-controlled multicenter clinical trial targeting subjects with moderate to severe plaque psoriasis.
Study Start Date: Sept. 26
Study Type: INTERVENTIONAL
Condition:
Plaque Psoriasis
Intervention:
DRUG: D-2570
Randomized in a 1:1:1 ratio through the randomization system, and assigned to D-2570 group1, group 2 or placebo group.
DRUG: Placebo
Randomized in a 1:1:1 ratio through the randomization system, and assigned to D-2570 group1, group 2 or placebo grou...